BACK TALK

Your PharmaScope 2016

If we don't clean up our act and do something about predatory pricing scandals, we'll wind up with Washington bureaucrats telling us what we can charge for our products.

A Faster FDA Approval Rate Key to Price Debate

Apparently, Dr. Ezekiel Emanuel loves to open his window and shout "fire!"

Back Talk: Who's Aiming for the Feet?

That 700% price hike created an issue that threatens years of pharma progress

Back Talk: Hail to the . . . CEO?

Back Talk: Is Cost Myopia Unfocused?

Before you fire up your outrage and vent your spleen, take a long look inside your parents' (or your own) medicine chest

Leadership and Truth

In Jack Welch's view, one of the worst mistakes a manager can make is . . .

Back Talk: In a Jam? Do the Right Thing

A textbook example of a firm doing the right thing in a crisis: J&J's decisive crisis management saved a brand

Who Will Pay the Piper?

Robbing pharma to pay Senator Pothole will not encourage innovation

Email Newsletters